Acyclovir-d4

CAT: 0804-HY-17422S1-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-17422S1-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Acyclovir-d4 is the deuterium labeled Acyclovir. Acyclovir (Aciclovir) is a guanosine analogue and an orally active antiviral agent. Acyclovir inhibits HSV-1 (IC50 of 0.85 μM), HSV-2 (IC50 of 0.86 μM) and varicella-zoster virus. Acyclovir can be phosphorylated by viral thymidine kinase (TK), and Acyclovir triphosphate interferes with viral DNA polymerization through competitive inhibition with guanosine triphosphate and obligatory chain termination[1][2][3]. Acyclovir prevents bacterial infections during induction therapy for acute leukaemia[4].
CAS Number
[1185179-33-2]
Product Name Alternative
Aciclovir-d4; Acycloguanosine-d4
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Antibiotic; Apoptosis; Bacterial; HSV; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Apoptosis; Others
Field of Research
Cancer; Infection
Purity
98.66
Solubility
10 mM in DMSO
Smiles
O=C1NC(N)=NC2=C1N=CN2COC([2H])([2H])C([2H])([2H])O
Molecular Formula
C8H7D4N5O3
Molecular Weight
229.23
Precautions
H315, H319, H335
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Li Z, et al. Acyclovir treatment of skin lesions results in immune deviation in mice infected cutaneously with herpes simplex virus. Antivir Chem Chemother. 1999 Sep;10 (5) :251-7.|[3]Lönnqvist B, et al. Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. Support Care Cancer. 1993 May;1 (3) :139-44.|[4]Suzuki M, et al. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus. Antiviral Res. 2006 Nov;72 (2) :157-61.|[5]Benedetti S, et al. Acyclovir induces cell cycle perturbation and apoptosis in Jurkat leukemia cells, and enhances chemotherapeutic drug cytotoxicity. Life Sci. 2018 Dec 15;215:80-85.|[6]Hayashi K, et al. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. J Gene Med. 2006 Aug;8 (8) :1056-67.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-17422-01Acyclovir
HY-17422A-01Acyclovir (sodium)
HY-17422DAcyclovir (hydrochloride)
HY-17422R-01Acyclovir (Standard)
HY-17422CAcyclovir alaninate
HY-17422B-01Acyclovir monophosphate
HY-19187Acyclovir elaidate
HY-142028A-01Acyclovir triphosphate (sodium)
HY-137362-01N2-Acetyl acyclovir
HY-137362R-01N2-Acetyl acyclovir (Standard)

Alternative Products

CatalogName
TRC-A192402-1MGAcyclovir-d4
TRC-A192407-100MGAcyclovir-d4 Benzoate
452496-01Iso-acyclovir-d4
TRC-A192427-50MGAcyclovir-d4 L-Leucinate
TRC-A168017-25MGN2-Acetyl Acyclovir-d4
TRC-A167977-25MGN2-Acetyl Acyclovir Benzoate-d4
MBS6035288-01Acyclovir-d4 (9-[(2-Hydroxyethoxy-d4)methyl]guanine, Acycloguanosine-d4)
A0858-52Acyclovir-d4 (9-[ (2-Hydroxyethoxy-d4) methyl]guanine, Acycloguanosine-d4)
A0202-02N2-Acetyl-9- (2-acetoxyethoxymethyl-d4) guanine (Diacetyl Acyclovir-d4)
MBS6065454-01N2-Acetyl-9-(2-acetoxyethoxymethyl-d4)guanine (Diacetyl Acyclovir-d4)

Popular Products